European Journal of Surgical Oncology
Volume 36, Issue 4 , Pages 358-364 , April 2010

Prolonged chemotherapy impairs liver regeneration after portal vein occlusion – An audit of 26 patients

  • C. Sturesson

      Affiliations

    • Department of Surgery, Lund University and Lund University Hospital, S-221 85 Lund, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 46 172347; fax: +46 46 172335.
    • ,
  • I. Keussen

      Affiliations

    • Department of Radiology, Lund University and Lund University Hospital, Lund, Sweden
    • ,
  • K.-G. Tranberg

      Affiliations

    • Department of Surgery, Lund University and Lund University Hospital, S-221 85 Lund, Sweden

,Accepted 7 December 2009.

References 

  1. Shoup M, Gonen M, D'Angelica M, et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg. 2003;7:325–330
  2. Madoff DC, Abdalla EK, Vauthey J-N. Portal vein embolization in preparation for major hepatic resection. Evolution of a new standard of care. J Vasc Interv Radiol. 2005;16:779–790
  3. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey J-N. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007;94:1386–1394
  4. Nordlinger B, Sorbye H, Collette L, et al. Final results of the EORTC intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. J Clin Oncol. 2007;25S:LBA5
  5. Tanaka K, Adam R, Shimada H, Azoulay D, Lévi F, Bismuth H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg. 2003;90:963–969
  6. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy. A model to predict long-term survival. Ann Surg. 2004;240:644–657
  7. Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460–466
  8. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006;243:1–7
  9. Vauthey J-N, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065–2072
  10. Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231:480–486
  11. Goéré D, Farges O, Leporrier J, Sauvanet A, Vilgrain V, Belghiti J. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg. 2006;10:366–370
  12. Beal IK, Anthony S, Papadopoulou A, et al. Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effect of periprocedure chemotherapy. Br J Radiol. 2006;79:473–478
  13. Tanaka Y, Nagasue N, Kanashima R, Inokuchi K, Sirota A. Effect of doxorubicin on liver regeneration and host survival after two-thirds hepatectomy in rats. Cancer. 1982;49:19–24
  14. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205–216
  15. Balzan S, Belghiti J, Farges O, et al. The “50–50 criteria” on postoperative day 5. An accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824–829
  16. Tanaka K, Shimada H, Matsuo K, ueda M, Endo I, Togo S. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur J Surg Oncol. 2007;33:329–335
  17. Giraudo G, Greget M, Oussoultzoglou E, Rosso E, Bachellier P, Jaeck D. Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery. 2008;143:476–482
  18. Covey AM, Brown KT, Jarnagin WR, et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg. 2008;247:451–455
  19. Bouzari H, Amisano M, Zorzi D, Vigano L, Capussotti L, Muratore A. Hypertrophy of the future liver remnant volume following portal vein occlusion. Portal vein embolization vs portal ligation. HPB. 2006;8(S2):27–28
  20. Aussilhou B, Lesurtel M, Sauvanet A, et al. Right portal vein ligation is as efficient as portal embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg. 2008;12:297–303
  21. Broering DC, Hillert C, Krupski G, et al. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg. 2002;6:905–913
  22. Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey J-N. Total and segmental liver volume variations: implications for liver surgery. Surgery. 2004;135:404–410
  23. Nagino M, Ando M, Kamiya J, Uesaka K, Sano T, Nimura Y. Liver regeneration after major hepatectomy for biliary cancer. Br J Surg. 2001;88:1084–1091
  24. Imamura H, Shimada R, Kubota M, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology. 1999;29:1099–1105
  25. Nanashima A, Sumida Y, Shibasaki S, et al. Parameters associated with changes in liver volume in patients undergoing portal vein embolization. J Surg Res. 2006;133:95–101
  26. Welsh FKS, Tilney HS, Tekkis PP, John TG, Rees M. Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer. 2007;96:1037–1042
  27. Capussotti L, Muratore A, Ferrero A, Anselmetti GC, Corgnier A, Regge D. Extension of right portal vein embolization to segment IV portal branches. Arch Surg. 2005;140:1100–1103
  28. Covey AM, Tuorto S, Brody LA, et al. Safety and efficacy of preoperative portal vein embolization with polyvinyl alcohol in 58 patients with liver metastases. Am J Roentgenol. 2005;185:1620–1626
  29. Madoff DC, Abdalla EK, Gupta S, et al. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol. 2005;16:215–225
  30. Dagher I, lainas P, Boudechiche L, et al. L'embolisation portale réversible induit une régénération hépatique efficace. Ann Chir. 2006;131:665

PII: S0748-7983(09)00542-3

doi: 10.1016/j.ejso.2009.12.001

European Journal of Surgical Oncology
Volume 36, Issue 4 , Pages 358-364 , April 2010

Article Tools

* Image Usage & Resolution